Literature DB >> 7858436

Intussusception in infants and children: risk factors leading to surgical reduction.

J L Chung1, M S Kong, J N Lin, K L Wang, C C Lou, H F Wong.   

Abstract

Intussusception is commonly the etiology of intestinal obstruction in infants and children. To investigate demographic data, clinicopathologic features and therapeutic prognosis of patients with intussusception, we reviewed 361 intussusceptions in 333 patients over an 11-year period. Most patients were below two years of age and there was a male preponderance of 1.6:1. There was no seasonal difference between the number of cases. The clinical triad of vomiting, abdominal colicky pain and bloody stools was manifested in only one-third of our patients. Secondary intussusception contributed to 6.6% of cases and Meckel's diverticulum was the most common pathologic cause. Positive findings were recorded in 82% of 67 patients undergoing sonographic examination. Intussusception of the ileo-colic type was most frequently encountered. Most patients (79%) were diagnosed within 48 hours and almost all cases underwent primary barium enema reduction. The success rate was 45%. Laparotomy was performed in 207 patients (57%) refractory to enema reduction or with critical illness, and intestinal resection was required in 28 (14%). Long-standing duration of illness (> 24 hours), positive clinical triad, positive pathologic lead point, and radiologic finding of bowel obstruction were identified as risk factors leading patients to surgical reduction (p < 0.001). Postoperative complications and recurrent intussusception developed in some patients, and the overall mortality was 0.6%. The clinical characteristics of intussusception in children generally remained unchanged as compared to previous reports. Early identification of patients with risk factors for surgical treatment is important to decrease the need for intestinal resection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7858436

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  7 in total

Review 1.  Beyond pancreatic insufficiency and liver disease in cystic fibrosis.

Authors:  Stephanie Demeyer; Kris De Boeck; Peter Witters; Katrien Cosaert
Journal:  Eur J Pediatr       Date:  2016-04-07       Impact factor: 3.183

2.  Endoscopic treatment of a large colonic polyp as a cause of colocolonic intussusception in a child.

Authors:  Nutnicha Suksamanapun; Mongkol Uiprasertkul; Ravit Ruangtrakool; Thawatchai Akaraviputh
Journal:  World J Gastrointest Endosc       Date:  2010-07-16

3.  Delays in presentation of intussusception and development of gangrene in Zimbabwe.

Authors:  Dennis Mazingi; Eleanor Burnett; Hilda Angela Mujuru; Kusum Nathoo; Jacqueline Tate; Jason Mwenda; Goitom Weldegebriel; Portia Manangazira; Arnold Mukaratirwa; Umesh Parashar; Taurai Zimunhu; Bothwell Anesu Mbuwayesango
Journal:  Pan Afr Med J       Date:  2021-07-28

4.  Childhood intussusceptions at a tertiary care hospital in northwestern Tanzania: a diagnostic and therapeutic challenge in resource-limited setting.

Authors:  Phillipo L Chalya; Neema M Kayange; Alphonce B Chandika
Journal:  Ital J Pediatr       Date:  2014-03-11       Impact factor: 2.638

5.  Sonographic guided hydrostatic saline enema reduction of childhood intussusception: a prospective study.

Authors:  Ademola Olusegun Talabi; Olusola Comfort Famurewa; Kayode Taiwo Bamigbola; Oludayo Adedapo Sowande; Babalola Ishmael Afolabi; Olusanya Adejuyigbe
Journal:  BMC Emerg Med       Date:  2018-11-21

6.  Factors Associated with a Failed Nonoperative Reduction of Intussusception in Children.

Authors:  Bahubali Deepak Gadgade; Veerabhadra Radhakrishna; Nitin Kumar
Journal:  J Indian Assoc Pediatr Surg       Date:  2021-11-12

7.  Prognostic indicators for failed nonsurgical reduction of intussusception.

Authors:  Jiraporn Khorana; Jesda Singhavejsakul; Nuthapong Ukarapol; Mongkol Laohapensang; Jakraphan Siriwongmongkol; Jayanton Patumanond
Journal:  Ther Clin Risk Manag       Date:  2016-08-09       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.